Connor, Clark & Lunn Investment Management Ltd. Invitae Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $21.8 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$26.09 - $40.4 $1.99 Million - $3.07 Million
-76,100 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$33.06 - $56.93 $1.69 Million - $2.91 Million
51,117 Added 204.61%
76,100 $2.91 Million
Q4 2020

Feb 16, 2021
BUY
$39.09 - $57.4 $576,538 - $846,592
14,749 Added 144.12%
24,983 $1.05 Million
Q3 2020

Nov 12, 2020
BUY
$28.43 - $44.67 $290,952 - $457,152
10,234 New
10,234 $444,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email